Metropolis Healthcare Ltd., a prominent diagnostic service provider, reported its unaudited consolidated financial results for Q1FY24. The company's core business revenue, excluding Covid and Covid Allied, PPP contracts, reached ₹271 crores, showing a 12% YoY growth.
The company's core business revenue, EBIDTA margin, and profit after tax stood at Rs. 271 crores, 24.2%, and ₹29 crores, respectively.
. Read more on livemint.com